As of 4:00pm ET
| +0.65 / +0.94%|
The 4 analysts offering 12-month price forecasts for Magellan Health Inc have a median target of 67.00, with a high estimate of 77.00 and a low estimate of 50.00. The median estimate represents a -4.11% decrease from the last price of 69.87.
The current consensus among 5 polled investment analysts is to Hold stock in Magellan Health Inc. This rating has held steady since April, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.